854 Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 6
Rolfe et al.
(2) (a) Nicolaou, K. C.; Chen, J. S. Chem. Soc. ReV. 2009, 11,
2993–3009. (b) Enders, D.; Grondal, C.; Hu¨ttl, M. R. M.
Angew. Chem., Int. Ed. 2007, 46, 1570–1581. (c) Tietze, L. F.;
Beifuss, U. Angew. Chem., Int. Ed. Engl. 1993, 32, 131–163.
(d) Tietze, L. F., Brasche, G., Gericke, K. M., Eds.; Wiley-
VCH: Weinheim, Germany, 2006. (e) Rolfe, A.; Young, K.;
Hanson, P. R. Eur. J. Org. Chem. 2008, 5254–5262.
(3) (a) Drews, J. Science 2000, 287, 1960–1964. (b) Scozzafaa,
A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Curr. Med.
Chem. 2003, 10, 925–953.
(4) Zhuang, L.; Wai, J. S.; Embrey, M. W.; Fisher, T. E.;
Egbertson, M. S.; Payne, L. S.; Guare, J. P., jr.; Vacca, J. P.;
Hazuda, D. J.; Felock, P. J.; Wolfe, A. L.; Stillmock, K. A.;
Witmer, M. V.; Moyer, G.; Schleif, W. A.; Gabryelski, L. J.;
Leonard, Y. M.; Lynch, J. J., Jr.; Michelson, S. R.; Young,
S. D. J. Med. Chem. 2003, 46, 453–456.
1M). The microwave vial was heated at 110 °C for 20 min,
after such time the reaction was purified (directly loading
of crude reaction mixture) by flash chromatography (8:2
hexane/EtOAc) to afford the desired sultam.
General Procedure B for the Synthesis of Library
Members. Into a 1-dram vial was added Cs2CO3 (0.17 g,
0.54 mmol, 3 equiv), a stock solution of corresponding
sultam (0.136 mmol) in dry DMSO (70 µL) (stock solution
A) and nucleophile (0.40 mmol, 3 equiv). The reaction was
heated in microwave at 110 °C for 30 min, followed by
cooling to RT. To the crude reaction mixture was added a
stock solution of ODCT50 (70 mg) in dry CH2Cl2 (1 mL),
and the crude reaction mixture was heated at 60 °C for an
additional 30 min in the microwave. After such time, the
crude reaction mixture was diluted (hexane:EtOAc, 1 mL)
and filtered through a silica SPE, flushing with solvent
(hexane:EtOAc, 5 mL). The resulting organic filtrate was
concentrated and analyzed by HPLC (UV 214 nm). Crude
material with purity below 90% was submitted to purification
by mass-directed fractionation (MDF).
(5) Levy, L. Drugs Future 1992, 17, 451–454.
(6) Rabasseda, X.; Hopkins, S. L. Drugs Today 1994, 30, 557–
563.
(7) Hendrick, R. T.; Spencer, S. R.; Blake, J. F.; Fell, J. B.;
Fischer, J. P.; Stengel, P. J.; Leveque, V. J. P.; LePogam, S.;
Rajyaguru, S.; Najera, I.; Joesy, J. A.; Swallow, S. Bioorg.
Med. Chem. Lett. 2009, 19, 410–414.
(8) Valente, C.; Guedes, R. C.; Moreira, R.; Iley, J.; Gut, J.;
Rosental, P. J. Biorg. Med. Chem. Lett. 2006, 16, 4115–4119.
(9) Misu, Y.; Togo, H. Org. Biomol. Chem. 2003, 1, 1342–1346.
(10) Rogers, K. Patzke, H. U.S. Patent 0050,545P Nov 12, 2005.
(11) Campbell, L.; Pike, K. G.; Suleman, A.; Waring, M. J.
W.O.Patent 050,101 May 2, 2008.
(12) Matsumoto, T.; Kamo, I.; Nomura, I. W.O. Patent 8,007,661
Jan 17, 2008.
(13) Santora, V. J.; Covel, J. A.; Ibarra, J. B.; Semple, G.; Smith,
B.; Smith, J.; Weinhouse, M. I.; Schultz, J. A. W.O. Patent
8, 097, 261 Jan 10, 2008.
(14) Fotouhi, N.; Haley, G. J.; Simonsen, K. B.; Vu, B. T.; Webber,
S. E. W.O. Patent 6,097,261 Sep. 21, 2006.
(15) Askew, jr., B. C.; Aya, T.; Biswas, K.; Cai, G.; Chen, J. J.;
Fotsch, C. H.; Han, N.; Human, J. B.; Li, A.; Liu, Q.; Peterkin,
T.; Qian, W.; Riahi, B.; Yuan, C. C.; Zhu, J. W.O. Patent
6,036,664 Apr 6, 2006.
Acknowledgment. This research was made possible by
generous funds provided by the National Institute of General
Medical Sciences [Pilot-Scale Libraries Program (P41
GM076302)], and The University of Kansas Center for
Chemical Methodologies and Library Development (KU-
CMLD) (P50 GM069663). Undergraduate funding was
provided by the NIH K-INBRE award and KU Center for
Research (S.V.K and M.B).
Supporting Information Available. Experimental pro-
cedures, tabulated results for all libraries, and full charac-
terization data for representative compounds. This material
acs.org.
(16) Grove, S. J. A.; Zhang, M.; Shahid, M. W.O. Patent 2,100,865
Dec 19, 2002.
(17) Duan, J.; Chen, L.: Cherney, R. J.; Decicco, C. P.; Voss, M. E.;
W.O. Patent 1, 994, 126 Aug 19, 1988.
(18) Rolfe, A.; Samarakoon, T. B.; Hanson, P. R. Org. Lett. 2010,
References and Notes
(1) For reviews concerning ROMP reagents, see: (a) Barrett,
A. G. M.; Hopkins, B. T.; Ko¨bberling, J. Chem. ReV 2002,
102, 3301–3324. (b) Flynn, D. L.; Hanson, P. R.; Berk, S. C.;
Makara, G. M. Curr. Opin. Drug DiscoVery DeV. 2002, 5,
571–579. (c) Harned, A. M.; Probst, D. A.; Hanson, P. R.
The Use of Olefin Metathesis in Combinatorial Chemistry:
Supported and Chromatography-Free Syntheses. In Handbook
of Metathesis; Grubbs, R. H., Ed.: Wiley-VCH: Weinheim,
Germany, 2003; pp 361-402. (d) Harned, A. M.; Zhang, M.;
Vedantham, P.; Mukherjee, S.; Herpel, R. H.; Flynn, D. L.;
Hanson, P. R. Aldrichimica Acta 2005, 38, 3–16.
12, 1216–1219.
(19) Rolfe, A.; Probst, D.; Volp, K. A.; Omar, I.; Flynn, D.;
Hanson, P. R. J. Org. Chem. 2008, 73, 8785–8790.
(20) 3 equivalents of scavenger was utilized as previous results
had demonstrated that DMSO adds to 2GODCT50 to form an
activated species and hence would be scavenged by it from
the crude reaction mixture, see ref 19.
(21) Grubbs, R. H.; Rosen, R. K. Organometallics 1996, 15,
1518–1520.
CC1001023